Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it ...

Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – and saving patients' lives.

The Parker Institute for Cancer Immunotherapy (PICI) today announced a strategic integration with the Cancer Vaccine ...

At present, only around 5% of patients with colon cancer are candidates for immunotherapy. This new biomarker could make it possible to determine more accurately which individuals may receive this ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Study also identifies potential path to making immunotherapy effective against the deadly, treatment-resistant cancer Katelyn ...

Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...